New concepts in pathogenesis and treatment of diabetic retinopathy.
about
Adeno-associated virus type-2 expression of pigmented epithelium-derived factor or Kringles 1-3 of angiostatin reduce retinal neovascularizationMedical treatment of diabetic retinopathy with somatostatin analogues.S100A4 is upregulated in proliferative diabetic retinopathy and correlates with markers of angiogenesis and fibrogenesis.Expression of lysophosphatidic acid, autotaxin and acylglycerol kinase as biomarkers in diabetic retinopathy.Neurotrophins and neurotrophin receptors in proliferative diabetic retinopathy.Relationship between vitreous levels of matrix metalloproteinases and vascular endothelial growth factor in proliferative diabetic retinopathyBlockade of NADPH oxidase restores vasoreparative function in diabetic CD34+ cells.Towards optimal filtering of "standard" multifocal electroretinogram (mfERG) recordings: findings in normal and diabetic subjectsHigh-mobility group box-1 and endothelial cell angiogenic markers in the vitreous from patients with proliferative diabetic retinopathyCoexpression of heparanase activity, cathepsin L, tissue factor, tissue factor pathway inhibitor, and MMP-9 in proliferative diabetic retinopathy.Adiponectin suppresses pathological microvessel formation in retina through modulation of tumor necrosis factor-alpha expression.Nerve growth factor in diabetic retinopathy: beyond neurons.Association of HMGB1 with oxidative stress markers and regulators in PDR.Association of 150-kDa oxygen-regulated protein with vascular endothelial growth factor in proliferative diabetic retinopathy.Differential expression and localization of human tissue inhibitors of metalloproteinases in proliferative diabetic retinopathy.Unbalanced Vitreous Levels of Osteoprotegerin, RANKL, RANK, and TRAIL in Proliferative Diabetic Retinopathy.Extracellular matrix metalloproteinase inducer (EMMPRIN) is a potential biomarker of angiogenesis in proliferative diabetic retinopathy.Upregulation of Thrombin/Matrix Metalloproteinase-1/Protease-Activated Receptor-1 Chain in Proliferative Diabetic Retinopathy.Angiogenesis regulatory factors in the vitreous from patients with proliferative diabetic retinopathy.Aqueous humor and plasma adiponectin levels in proliferative diabetic retinopathy patients.Matrix metalloproteinase-14 is a biomarker of angiogenic activity in proliferative diabetic retinopathy.The Oxidative Stress and Mitochondrial Dysfunction during the Pathogenesis of Diabetic Retinopathy
P2860
Q31081886-6C8E5EDC-8EA3-4582-8641-1CFB25EFCCB2Q33265910-A379C35C-BCE7-413B-8C68-6FA9D90C9884Q34161174-557C4FF0-D658-45CC-ACFE-6FB0A422517EQ34292377-39CF1495-C6AC-4A4C-B4D6-B8B93A041462Q34769969-36D77FA6-590D-4CCA-80C9-5F132A3C1825Q35083186-6F228F40-D027-429D-B308-5EF08E2E640FQ35221390-F9565000-A361-4377-9772-93F36334E79CQ35591908-40D854DD-5BAC-4835-8DE4-63286CA667C2Q36340353-2D1FFE64-3397-4728-B83C-4820055E1206Q36853911-061F246C-7597-4850-80A2-5343A6507EECQ37339479-814F5741-3617-424D-9495-8BA4E16B981AQ38230380-78C01E8B-38C3-46AF-952F-E143A29BBA90Q47108366-5E4F4F13-A9C6-43BC-80FF-F2261D00821AQ47446172-CC5B855E-220F-4355-B95F-6928ED68B437Q48300010-D78AD272-375D-492E-B9AF-65388D4B4EFBQ50071959-C08E72FB-DEA7-407F-9E8B-7F84C133F5A0Q51319850-90425B2D-517E-4309-A1EF-ABA6487D2793Q51720742-CF855F6E-3486-48FF-B08D-783E3FCC3247Q53981732-B68EEF8A-992F-4444-AC9C-D3568842126BQ54311414-7CF425DF-627D-4ABE-94A3-7570D4893547Q55097343-EA697307-A7A1-457F-B3A9-950EBCFE9160Q58762667-14EFF725-FEBD-402B-96DB-149933469AFF
P2860
New concepts in pathogenesis and treatment of diabetic retinopathy.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
New concepts in pathogenesis and treatment of diabetic retinopathy.
@ast
New concepts in pathogenesis and treatment of diabetic retinopathy.
@en
New concepts in pathogenesis and treatment of diabetic retinopathy.
@nl
type
label
New concepts in pathogenesis and treatment of diabetic retinopathy.
@ast
New concepts in pathogenesis and treatment of diabetic retinopathy.
@en
New concepts in pathogenesis and treatment of diabetic retinopathy.
@nl
prefLabel
New concepts in pathogenesis and treatment of diabetic retinopathy.
@ast
New concepts in pathogenesis and treatment of diabetic retinopathy.
@en
New concepts in pathogenesis and treatment of diabetic retinopathy.
@nl
P356
P1476
New concepts in pathogenesis and treatment of diabetic retinopathy.
@en
P2093
Pfeiffer AF
Spranger J
P304
P356
10.1055/S-2001-18601
P478
109 Suppl 2
P577
2001-01-01T00:00:00Z